恶性骨髓疾病中的一种常见遗传机制。 - Suppr

Suppr

超能文献

A common genetic mechanism in malignant bone marrow diseases.

作者信息

Levine Ross L, Carroll Martin

出版信息

N Engl J Med. 2009 May 28;360(22):2355-7. doi: 10.1056/NEJMe0902257.

DOI:10.1056/NEJMe0902257

PMID:19474434

Abstract

摘要

相似文献

A common genetic mechanism in malignant bone marrow diseases.

N Engl J Med. 2009 May 28;360(22):2355-7. doi: 10.1056/NEJMe0902257.

Mutation in TET2 in myeloid cancers.

N Engl J Med. 2009 May 28;360(22):2289-301. doi: 10.1056/NEJMoa0810069.

Effect of mutation order on myeloproliferative neoplasms.

N Engl J Med. 2015 May 7;372(19):1865-6. doi: 10.1056/NEJMc1503143.

Effect of mutation order on myeloproliferative neoplasms.

N Engl J Med. 2015 May 7;372(19):1865. doi: 10.1056/NEJMc1503143.

Genetics: Myeloproliferative neoplasms—order of mutations counts!

Nat Rev Clin Oncol. 2015 Apr;12(4):187. doi: 10.1038/nrclinonc.2015.39. Epub 2015 Mar 3.

[Mutations in TET2 in myeloid cancers].

Med Sci (Paris). 2009 Oct;25(10):785-8. doi: 10.1051/medsci/20092510785.

Tumorigenesis: Order matters.

Nat Rev Genet. 2015 Apr;16(4):193. doi: 10.1038/nrg3923.

Tumorigenesis: Order matters.

Nat Rev Cancer. 2015 Apr;15(4):196-7. doi: 10.1038/nrc3926. Epub 2015 Mar 5.

Cancer evolution constrained by mutation order.

N Engl J Med. 2015 Feb 12;372(7):661-3. doi: 10.1056/NEJMe1414288.

Mutations of IDH1 and IDH2 genes in early and accelerated phases of myelodysplastic syndromes and MDS/myeloproliferative neoplasms.

Leukemia. 2010 May;24(5):1094-6. doi: 10.1038/leu.2010.52. Epub 2010 Apr 8.

引用本文的文献

Splicing factor mutations in myelodysplasia.

Int J Hematol. 2012 Oct;96(4):438-42. doi: 10.1007/s12185-012-1182-y. Epub 2012 Oct 5.

SNPs array karyotyping reveals a novel recurrent 20p13 amplification in primary myelofibrosis.

PLoS One. 2011;6(11):e27560. doi: 10.1371/journal.pone.0027560. Epub 2011 Nov 14.

Epigenetics of haematopoietic cell development.

Nat Rev Immunol. 2011 Jun 10;11(7):478-88. doi: 10.1038/nri2991.

Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2.

Nature. 2010 Dec 9;468(7325):839-43. doi: 10.1038/nature09586.

Mouse models of cancer as biological filters for complex genomic data.

Dis Model Mech. 2010 Nov-Dec;3(11-12):701-4. doi: 10.1242/dmm.006296. Epub 2010 Sep 27.

The behaviour of 5-hydroxymethylcytosine in bisulfite sequencing.

PLoS One. 2010 Jan 26;5(1):e8888. doi: 10.1371/journal.pone.0008888.

The first 30 years of p53: growing ever more complex.

Nat Rev Cancer. 2009 Oct;9(10):749-58. doi: 10.1038/nrc2723.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

A common genetic mechanism in malignant bone marrow diseases.

N Engl J Med. 2009 May 28;360(22):2355-7. doi: 10.1056/NEJMe0902257.

Mutation in TET2 in myeloid cancers.

N Engl J Med. 2009 May 28;360(22):2289-301. doi: 10.1056/NEJMoa0810069.

Effect of mutation order on myeloproliferative neoplasms.

N Engl J Med. 2015 May 7;372(19):1865-6. doi: 10.1056/NEJMc1503143.

Effect of mutation order on myeloproliferative neoplasms.

N Engl J Med. 2015 May 7;372(19):1865. doi: 10.1056/NEJMc1503143.

Genetics: Myeloproliferative neoplasms—order of mutations counts!

Nat Rev Clin Oncol. 2015 Apr;12(4):187. doi: 10.1038/nrclinonc.2015.39. Epub 2015 Mar 3.

[Mutations in TET2 in myeloid cancers].

Med Sci (Paris). 2009 Oct;25(10):785-8. doi: 10.1051/medsci/20092510785.

Tumorigenesis: Order matters.

Nat Rev Genet. 2015 Apr;16(4):193. doi: 10.1038/nrg3923.

Tumorigenesis: Order matters.

Nat Rev Cancer. 2015 Apr;15(4):196-7. doi: 10.1038/nrc3926. Epub 2015 Mar 5.

Cancer evolution constrained by mutation order.

N Engl J Med. 2015 Feb 12;372(7):661-3. doi: 10.1056/NEJMe1414288.

Mutations of IDH1 and IDH2 genes in early and accelerated phases of myelodysplastic syndromes and MDS/myeloproliferative neoplasms.

Leukemia. 2010 May;24(5):1094-6. doi: 10.1038/leu.2010.52. Epub 2010 Apr 8.

引用本文的文献

Splicing factor mutations in myelodysplasia.

Int J Hematol. 2012 Oct;96(4):438-42. doi: 10.1007/s12185-012-1182-y. Epub 2012 Oct 5.

SNPs array karyotyping reveals a novel recurrent 20p13 amplification in primary myelofibrosis.

PLoS One. 2011;6(11):e27560. doi: 10.1371/journal.pone.0027560. Epub 2011 Nov 14.

Epigenetics of haematopoietic cell development.

Nat Rev Immunol. 2011 Jun 10;11(7):478-88. doi: 10.1038/nri2991.

Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2.

Nature. 2010 Dec 9;468(7325):839-43. doi: 10.1038/nature09586.

Mouse models of cancer as biological filters for complex genomic data.

Dis Model Mech. 2010 Nov-Dec;3(11-12):701-4. doi: 10.1242/dmm.006296. Epub 2010 Sep 27.

The behaviour of 5-hydroxymethylcytosine in bisulfite sequencing.

PLoS One. 2010 Jan 26;5(1):e8888. doi: 10.1371/journal.pone.0008888.

The first 30 years of p53: growing ever more complex.

Nat Rev Cancer. 2009 Oct;9(10):749-58. doi: 10.1038/nrc2723.